Lerner Aaron, Shoenfeld Yehuda, Matthias Torsten
B. Rappaport School of Medicine, Technion-Israel Institute of Technology, Haifa 3200003, Israel.
AESKU.KIPP Institute, 55234 Wendelsheim, Germany.
Microorganisms. 2019 Apr 11;7(4):104. doi: 10.3390/microorganisms7040104.
Probiotics per definition should have beneficial effects on human health, and their consumption has tremendously increased in the last decades. In parallel, the amount of published material and claims for their beneficial efficacy soared continuously. Recently, multiple systemic reviews, meta-analyses, and expert opinions expressed criticism on their claimed effects and safety. The present review describes the dark side of the probiotics, in terms of problematic research design, incomplete reporting, lack of transparency, and under-reported safety. Highlighted are the potential virulent factors and the mode of action in the intestinal lumen, risking the physiological microbiome equilibrium. Finally, regulatory topics are discussed to lighten the heterogeneous guidelines applied worldwide. The shift in the scientific world towards a better understanding of the human microbiome, before consumption of the probiotic cargo, is highly endorsed. It is hoped that better knowledge will extend the probiotic repertoire, re-confirm efficacy or safety, establish their efficacy and substantiate their beneficial effects.
从定义上讲,益生菌应该对人体健康有有益影响,并且在过去几十年中其消费量大幅增加。与此同时,已发表的关于其有益功效的材料数量和相关声明也在持续飙升。最近,多项系统评价、荟萃分析和专家意见对其声称的效果和安全性提出了批评。本综述从研究设计存在问题、报告不完整、缺乏透明度以及安全性报告不足等方面描述了益生菌的阴暗面。重点介绍了潜在的毒力因子以及在肠腔内的作用方式,这可能会危及生理微生物群的平衡。最后,讨论了监管话题,以阐明全球范围内应用的各种不同指南。科学界在食用益生菌产品之前朝着更好地理解人类微生物群的转变得到了高度认可。希望更深入的了解将扩大益生菌的种类,重新确认其功效或安全性,确立其有效性并证实其有益效果。